The significance of the global blood flow measurement device market is expected to rise in the coming years, with the soaring incidence of vascular diseases, growing patient pool, and developing healthcare infrastructure.  Nearly 8,000,000 people in the United States suffered from peripheral arterial disease (PAD) in 2012, as reported by to the Centers for Disease Control and Prevention (CDC). Blood flow measurement devices play an important role in the diagnosis of vascular ailments, arterial disorders and complications. They have vast application in a number of procedures such as gastroenterology, cranial monitoring, dermatology, diabetes, and tumor monitoring.

A magnetic field is generated and transmitted into the liquid which flows through the pipe in a magnetic blood flow meter. Ultrasonic flow meters used to measure the fluid speed using the reflected ultrasonic sound. This type of stream meter can also be used to measure the blood stream by passing through the tissue with an ultrasonic beam and by bouncing off a spinal plate. Laser anemometry measurement Doppler is absolute, velocity-linear and does not need pre-calibration. The clinical applications of blood flow measurement devices are rising each passing day, boosting the growth of the global blood flow measurement devices market.

Leading factors driving the global blood flow measurement devices market are:

•   Favorable Regulations and Policies

Approvals of new blood flow meters with new state-of – the-art technology are gaining greater momentum on the market with the rising American Food and Drug Administration (US FDA). For example, Neural Analytics, Inc. recently announced the introduction of’ Autonomous Transcranial Robotic Doppler Technology.’ Their Lucid robotic system is a medical ultrasound system designed to be used in addition to standard CBFV test and display clinical practices and the occurrence of transient brain emboli. This is one of the most important factors fueling the market for blood flow measurement devices over the coming years.

•    Preference for Minimally Invasive Techniques

In the earlier days, epidurals were the first technique for pain relief. The pain-management sub-specialty was promoted in anesthesia by many techniques to alleviate or reduce minimally invasive pain. Blood flow measuring devices are likely to help patients achieve better quality of life in combination with other minimally invasive surgical techniques and non-operative methods and are expected to take a higher level of uptake in the next few years. The global blood flow measurement device market is expected to be fueled by this leading trend in the coming years.

Request Brochure of Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1419

•    Rising Expenditures on Healthcare

An immediate, reliable and non-invasive blood flow measurement technique could enable an effective disease to be diagnosed early and treated. In addition to increasing demand for noninvasive and technologically advanced instruments, and the patient pool ready to spend higher amounts of money on healthcare, there is expected to be unprecedented growth in the global blood flow measurement industry in the coming years.

Market players are developing novel products with significant research and development expenses in the blood flow measurement industry to take advantage of highly profitable opportunities. Medtronic Plc, for example, is the hardest competitor on the market. Their broad product portfolio and major investments in blood flow measurement devices are the main reason for that. Key players in the global blood flow measurement devices market are Arjohuntleigh, Biomedix Inc, Ace Medicals, Moor Instruments, and Cook Medical Inc

Leave a comment

Your email address will not be published. Required fields are marked *